CONSOLIDATED BALANCE SHEETS (UNAUDITED) - USD ($)	Jan. 31, 2016	Jul. 31, 2015
Current Assets:
Cash and cash equivalents	$ 31,768	$ 749,965
Other current assets	5,176	51,240
Total Current Assets	36,944	801,205
Property and Equipment, Net	1,938	2,869
Patents, Net	1,305,326	1,430,016
TOTAL ASSETS	1,344,208	2,234,090
Current Liabilities:
Accounts payable and accrued expenses (Note 4)	8,537,216	8,018,833
Total Current Liabilities	8,537,216	8,018,833
Derivative Warrant Liability (Note 7 and 8)	2,332,731	2,363,415
Derivative Additional Investment Rights Liability (Note 7 and 8)	276,980	142,662
Total Liabilities	11,146,927	10,524,410
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Common stock, $.001 par value; authorized 2,450,000,000 and 1,500,000,000 shares at January 31, 2016 and July 31, 2015, respectively; 870,325,348 and 825,496,238 issued and outstanding at January 31, 2016 and July 31, 2015, respectively	870,325	825,496
Additional paid-in capital	367,783,224	362,556,710
Accumulated deficit	(374,259,918)	(372,481,263)
Accumulated other comprehensive income	803,650	808,737
Total Stockholders' Deficiency	9,802,719	(8,290,320)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIENCY	1,344,208	2,234,090
Series A Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series B Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series C Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series D Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series E Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series F Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock
Series G Convertible Preferred Stock
Stockholders' Deficiency (Note 7):
9% Convertible Preferred Stock